Fingerprint
Dive into the research topics of 'Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically